Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.

AUTHOR

OTS

DATE

July 5, 2020

CATEGORIES

Immune Stimulation

Post Views: 314

Buss CG, Bhatia SN.

Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13428-13436.

Pubmed

Hybridization Liquid Chromatography-Tandem Mass Spectrometry: An Alternative Bioanalytical Method for Antisense Oligonucleotide Quantitation in Plasma and Tissue Samples.

Hybridization Liquid Chromatography-Tandem Mass Spectrometry: An Alternative Bioanalytical Method for Antisense Oligonucleotide Quantitation in Plasma and Tissue Samples.
August 5th, 2020|0 Comments
Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists

Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
July 5th, 2020|0 Comments
Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.

Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.
July 5th, 2020|0 Comments
Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial

Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial
May 15th, 2020|0 Comments
Vaccination against non-mutated neoantigens induced in recurrent and future tumors

Vaccination against non-mutated neoantigens induced in recurrent and future tumors
April 30th, 2020|0 Comments
Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses

Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses
February 29th, 2020|0 Comments

Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.

Related articles

Hybridization Liquid Chromatography-Tandem Mass Spectrometry: An Alternative Bioanalytical Method for Antisense Oligonucleotide Quantitation in Plasma and Tissue Samples.

Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists

Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.

Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial

Vaccination against non-mutated neoantigens induced in recurrent and future tumors

Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses

Login to your account

Reset Password

Signup to your Account

Answers

Job Alerts

Account Activation